Edoxaban is an oral tablet of selective coagulation factor Xa inhibitor for the prevention and treatment of deep venous thrombosis and pulmonary embolism. It is used to reduce the risk of stroke and systemic embolism in patients with non valvular atrial fibrillation (NVAF). At present, it has three specifications: 60mg, 30mg and 15mg.